Author: Natalya Bukreyeva; Emily K. Mantlo; Rachel A. Sattler; Cheng Huang; Slobodan Paessler; Jerry Zeldis
Title: The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro Document date: 2020_4_9
ID: geb4esu5_2
Snippet: The effect is dose-dependent, and concentrations as low as 3.3 μM significantly reduced viral titers when the cells were pretreated prior to infection. The results of this study provide evidence that MMPD may be a viable treatment option for COVID-19. Drugs with history of being tested in human patients or used for treatment of other conditions offer the most expedient option, and several such drugs are currently being tested for efficacy agains.....
Document: The effect is dose-dependent, and concentrations as low as 3.3 μM significantly reduced viral titers when the cells were pretreated prior to infection. The results of this study provide evidence that MMPD may be a viable treatment option for COVID-19. Drugs with history of being tested in human patients or used for treatment of other conditions offer the most expedient option, and several such drugs are currently being tested for efficacy against SARS-CoV-2, including many broad-spectrum antivirals. One such antiviral, merimepodib (MMPD), has already being tested against hepatitis C in patients as well as against many emerging RNA viruses in cell culture, including Zika, Ebola, Lassa, Junin, and . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.07.028589 doi: bioRxiv preprint chikungunya viruses (1) . MMPD noncompetitively inhibits inosine-5'-monophosphate dehydrogenase (IMPDH), an enzyme responsible for de novo synthesis of guanosine nucleotides (2, 3) . In vitro, inhibition can be reversed by addition of exogenous guanosine (4).
Search related documents:
Co phrase search for related documents- broad spectrum and condition treatment: 1, 2, 3, 4, 5
- broad spectrum and IMPDH dehydrogenase: 1, 2
- broad spectrum antiviral and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum antiviral and condition treatment: 1
- cell culture and condition treatment: 1
- cell culture and guanosine nucleotide: 1
- cell culture and human patient: 1, 2, 3, 4, 5
- cell culture and IMPDH dehydrogenase: 1
Co phrase search for related documents, hyperlinks ordered by date